Clinical Applications of Left Ventricular Opacification

JACC: Cardiovascular Imaging

Volumn 3, Issue 2, 2010, Pages 188-196

  Chahal, Navtej S ^a   Senior, Roxy ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

echocardiography; left ventricular; opacification

Indexed keywords

CONTRAST MEDIUM;

CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FALSE ANEURYSM; HEALTH CARE COST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RUPTURE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE QUALITY; PRIORITY JOURNAL; REVIEW;

ATTITUDE OF HEALTH PERSONNEL; CONTRAST MEDIA; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEART VENTRICLES; HUMANS; MICROBUBBLES; PHYSICIAN'S PRACTICE PATTERNS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 75949095774     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.09.022     Document Type: Review

References (36)

1. Yong Y., Wu D., Fernandes V., et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 89 (2002) 711-718
2. Al-Mansour H.A., Mulvagh S.L., Pumper G.M., Klarich K.W., and Foley D.A. Usefulness of harmonic imaging for left ventricular opacification and endocardial border delineation by optison. Am J Cardiol 85 (2000) 795-799
3. Cohen J.L., Cheirif J., Segar D.S., et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. J Am Coll Cardiol 32 (1998) 746-752
4. Kitzman D.W., Goldman M.E., Gillam L.D., Cohen J.L., Aurigemma G.P., and Gottdiener J.S. Efficacy and safety of the novel ultrasound contrast agent perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 86 (2000) 669-674
5. Mulvagh S.L., Rakowski H., Vannan M.A., et al. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr 21 (2008) 1179-1201
6. Senior R., Becher H., Monaghan M., et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr 10 (2009) 194-212
7. Hundley W.G., Kizilbash A.M., Afridi I., Franco F., Peshock R.M., and Grayburn P.A. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol 32 (1998) 1426-1432
8. Malm S., Frigstad S., Sagberg E., Larsson H., and Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 44 (2004) 1030-1035
9. Thomson H.L., Basmadjian A.J., Rainbird A.J., et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J Am Coll Cardiol 38 (2001) 867-875
10. Nahar T., Croft L., Shapiro R., et al. Comparison of four echocardiographic techniques for measuring left ventricular ejection fraction. Am J Cardiol 86 (2000) 1358-1362
11. Yu E.H., Sloggett C.E., Iwanochko R.M., Rakowski H., and Siu S.C. Feasibility and accuracy of left ventricular volumes and ejection fraction determination by fundamental, tissue harmonic, and intravenous contrast imaging in difficult-to-image patients. J Am Soc Echocardiogr 13 (2000) 216-224
12. Lim T.K., Burden L., Janardhanan R., et al. Improved accuracy of low-power contrast echocardiography for the assessment of left ventricular remodeling compared with unenhanced harmonic echocardiography after acute myocardial infarction: comparison with cardiovascular magnetic resonance imaging. J Am Soc Echocardiogr 18 (2005) 1203-1207
13. Jenkins C., Moir S., Chan J., Rakhit D., Haluska B., and Marwick T.H. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J 30 (2009) 98-106
14. Hoffmann R., von Bardeleben S., ten Cate F., et al. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J 26 (2005) 607-616
15. Thanigaraj S., Schechtman K.B., and Perez J.E. Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second-generation contrast image enhancement. J Am Soc Echocardiogr 12 (1999) 1022-1026
16. Soman P., Swinburn J., Callister M., Stephens N.G., and Senior R. Apical hypertrophic cardiomyopathy: bedside diagnosis by intravenous contrast echocardiography. J Am Soc Echocardiogr 14 (2001) 311-313
17. Koo B.K., Choi D., Ha J.W., Kang S.M., Chung N., and Cho S.Y. Isolated noncompaction of the ventricular myocardium: contrast echocardiographic findings and review of the literature. Echocardiography 19 (2002) 153-156
18. Mittle S., Makaryus A.N., and Mangion J. Role of contrast echocardiography in the assessment of myocardial rupture. Echocardiography 20 (2003) 77-81
19. Hoffmann R., Lethen H., Marwick T., et al. Standardized guidelines for the interpretation of dobutamine echocardiography reduce interinstitutional variance in interpretation. Am J Cardiol 82 (1998) 1520-1524
20. Ikonomidis I., Holmes E., Narbuvold H., Bolstad B., Muan B., and Nihoyannopoulos P. Assessment of left ventricular wall motion and delineation of the endocardial border after intravenous injection of Infoson during dobutamine stress echocardiography. Coron Artery Dis 9 (1998) 567-576
21. Malhotra V., Nwogu J., Bondmass M.D., et al. Is the technically limited echocardiographic study an endangered species?. Endocardial border definition with native tissue harmonic imaging and Optison contrast: a review of 200 cases. J Am Soc Echocardiogr 13 (2000) 771-773
22. Rainbird A.J., Mulvagh S.L., Oh J.K., et al. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 14 (2001) 378-385
23. Moir S., Haluska B.A., Jenkins C., Fathi R., and Marwick T.H. Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation 110 (2004) 1108-1113
24. Dolan M.S., Riad K., El-Shafei A., et al. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 142 (2001) 908-915
25. Plana J.C., Mikati I.A., Dokainish H., et al. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocariography in coronary artery disease. J Am Coll Cardiol Img 1 (2008) 145-152
26. Jung P.H., Rieber J., Stork S., et al. Effect of contrast application on interpretability and diagnostic value of dobutamine stress echocardiography in patients with intermediate coronary lesions: comparison with myocardial fractional flow reserve. Eur Heart J 29 (2008) 2536-2543
27. Moir S., Shaw L., Haluska B., Jenkins C., and Marwick T.H. Left ventricular opacification for the diagnosis of coronary artery disease with stress echocardiography: an angiographic study of incremental benefit and cost-effectiveness. Am Heart J 154 (2007) 510-518
28. Dwivedi G., Janardhanan R., Hayat S.A., Lim T.K., and Senior R. Improved prediction of outcome by contrast echocardiography determined left ventricular remodelling parameters compared to unenhanced echocardiography in patients following acute myocardial infarction. Eur J Echocardiogr 10 (2009) 933-940
29. Kurt M., Shaikh K.A., Peterson L., et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol 53 (2009) 802-810
30. Shaw L.J., Gillam L., Feinstein S., Dent J., and Plotnick G. Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Optison Multicenter Study Group. Am J Manag Care 4 (1998) SP169-SP176 Spec No
31. Thanigaraj S., Nease Jr. R.F., Schechtman K.B., Wade R.L., Loslo S., and Perez J.E. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Am J Cardiol 87 (2001) 1430-1432
32. Jeetley P., Burden L., Stoykova B., and Senior R. Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study. Eur Heart J 28 (2007) 204-211
33. U.S. Imaging Market Guide July-December 2008. Arlington Medical Resources, Arlington Medical Resource's Imaging Market Guide, December 2008
34. Castello R., Bella J.N., Rovner A., Swan J., Smith J., and Shaw L. Efficacy and time-efficiency of a "sonographer-driven" contrast echocardiography protocol in a high-volume echocardiography laboratory. Am Heart J 145 (2003) 535-541
35. Dolan M.S., Gala S.S., Dodla S., et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography: a multicenter experience. J Am Coll Cardiol 53 (2009) 32-38
36. Main M.L., Ryan A.C., Davis T.E., Albano M.P., Kusnetzky L.L., and Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol 102 (2008) 1742-1746